{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:33:05Z","timestamp":1770813185798,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fujian Provincial Health Commission Youth Scientific Research Project","award":["2023QNA037"],"award-info":[{"award-number":["2023QNA037"]}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2022J01222"],"award-info":[{"award-number":["2022J01222"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-35712-1","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T09:54:08Z","timestamp":1768816448000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correlations of m6A methylation-related mRNAs with thyroid cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Zhen","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingruo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huihao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruhai","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"35712_CR1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/s2213-8587(22)00035-3","volume":"10","author":"M Pizzato","year":"2022","unstructured":"Pizzato, M. et al. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol. 10, 264\u2013272. https:\/\/doi.org\/10.1016\/s2213-8587(22)00035-3 (2022).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"35712_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2022.101664","volume":"37","author":"P Pace-Asciak","year":"2023","unstructured":"Pace-Asciak, P., Russell, J. O. & Tufano, R. P. Surgical treatment of thyroid cancer: Established and novel approaches. Best Pract. Res. Clin. Endocrinol. Metab. 37, 101664. https:\/\/doi.org\/10.1016\/j.beem.2022.101664 (2023).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"35712_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2023.26348","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai, L., Zafereo, M. & Cabanillas, M. E. Thyroid cancer: A review. JAMA 331, 425\u2013435. https:\/\/doi.org\/10.1001\/jama.2023.26348 (2024).","journal-title":"JAMA"},{"key":"35712_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114500","volume":"238","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Targeted therapy and drug resistance in thyroid cancer. Eur. J. Med. Chem. 238, 114500. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114500 (2022).","journal-title":"Eur. J. Med. Chem."},{"key":"35712_CR5","doi-asserted-by":"publisher","unstructured":"Morton, L. M. et al. Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accident. Science (New York, N.Y.) https:\/\/doi.org\/10.1126\/science.abg2538 (2021).","DOI":"10.1126\/science.abg2538"},{"key":"35712_CR6","doi-asserted-by":"publisher","unstructured":"Zhang, L. et al. Molecular basis and targeted therapy in thyroid cancer: Progress and opportunities. Biochimica et Biophysica Acta (BBA) Rev. Cancer 1878, 188928. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188928 (2023).","DOI":"10.1016\/j.bbcan.2023.188928"},{"key":"35712_CR7","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1245\/s10434-016-5185-4","volume":"23","author":"MG White","year":"2016","unstructured":"White, M. G. et al. Epigenetic alterations and canonical pathway disruption in papillary thyroid cancer: A genome-wide methylation analysis. Ann. Surg. Oncol. 23, 2302\u20132309. https:\/\/doi.org\/10.1245\/s10434-016-5185-4 (2016).","journal-title":"Ann. Surg. Oncol."},{"key":"35712_CR8","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nchembio.687","volume":"7","author":"G Jia","year":"2011","unstructured":"Jia, G. et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat. Chem. Biol. 7, 885\u2013887. https:\/\/doi.org\/10.1038\/nchembio.687 (2011).","journal-title":"Nat. Chem. Biol."},{"key":"35712_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12943-023-01782-2","volume":"22","author":"H Zhuang","year":"2023","unstructured":"Zhuang, H. et al. The role of m6A methylation in therapy resistance in cancer. Mol. Cancer 22, 91. https:\/\/doi.org\/10.1186\/s12943-023-01782-2 (2023).","journal-title":"Mol. Cancer"},{"key":"35712_CR10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12943-020-01216-3","volume":"19","author":"Z Zhou","year":"2020","unstructured":"Zhou, Z. et al. Mechanism of RNA modification N6-methyladenosine in human cancer. Mol. Cancer 19, 104. https:\/\/doi.org\/10.1186\/s12943-020-01216-3 (2020).","journal-title":"Mol. Cancer"},{"key":"35712_CR11","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41580-023-00622-x","volume":"24","author":"H Sun","year":"2023","unstructured":"Sun, H., Li, K., Liu, C. & Yi, C. Regulation and functions of non-m(6)A mRNA modifications. Nat. Rev. Mol. Cell Biol. 24, 714\u2013731. https:\/\/doi.org\/10.1038\/s41580-023-00622-x (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"35712_CR12","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1002\/jcp.30733","volume":"237","author":"L Zheng","year":"2022","unstructured":"Zheng, L. et al. The emerging roles of the interaction between m6A modification and c-Myc in driving tumorigenesis and development. J. Cell. Physiol. 237, 2758\u20132769. https:\/\/doi.org\/10.1002\/jcp.30733 (2022).","journal-title":"J. Cell. Physiol."},{"key":"35712_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12943-022-01508-w","volume":"21","author":"L Liu","year":"2022","unstructured":"Liu, L. et al. Insights into N6-methyladenosine and programmed cell death in cancer. Mol. Cancer 21, 32. https:\/\/doi.org\/10.1186\/s12943-022-01508-w (2022).","journal-title":"Mol. Cancer"},{"key":"35712_CR14","doi-asserted-by":"publisher","unstructured":"Li, C., Xie, P., Lv, K., Yang, Q. & Mou, Y. METTL3-mediated m6A modification of hsa_circ_0131922 attenuates the progression of papillary thyroid cancer by regulating the p53 pathway. Endocr. Metab. Immune Disord. Drug Targets. https:\/\/doi.org\/10.2174\/0118715303290063240530053252 (2024).","DOI":"10.2174\/0118715303290063240530053252"},{"key":"35712_CR15","doi-asserted-by":"publisher","first-page":"992","DOI":"10.21037\/tcr-23-449","volume":"12","author":"X Zheng","year":"2023","unstructured":"Zheng, X. et al. N(6)-methyladenosine reader IGF2BP3 as a prognostic Biomarker contribute to malignant progression of glioma. Transl. Cancer Res. 12, 992\u20131005. https:\/\/doi.org\/10.21037\/tcr-23-449 (2023).","journal-title":"Transl. Cancer Res."},{"key":"35712_CR16","doi-asserted-by":"publisher","unstructured":"Xu, X. et al. The emerging roles of N6-methyladenosine RNA modifications in thyroid cancer. Eur. J. Med. Res. https:\/\/doi.org\/10.1186\/s40001-023-01382-2 (2023).","DOI":"10.1186\/s40001-023-01382-2"},{"key":"35712_CR17","doi-asserted-by":"publisher","unstructured":"Zhou, X. et al. The m6A methyltransferase METTL3 drives thyroid cancer progression and lymph node metastasis by targeting LINC00894. Cancer Cell Int. https:\/\/doi.org\/10.1186\/s12935-024-03240-5 (2024).","DOI":"10.1186\/s12935-024-03240-5"},{"key":"35712_CR18","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1210\/clinem\/dgab480","volume":"107","author":"S Lin","year":"2022","unstructured":"Lin, S. et al. METTL3-Induced miR-222-3p upregulation inhibits STK4 and promotes the malignant behaviors of thyroid carcinoma cells. J. Clin. Endocrinol. Metab. 107, 474\u2013490. https:\/\/doi.org\/10.1210\/clinem\/dgab480 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"35712_CR19","doi-asserted-by":"publisher","first-page":"11516","DOI":"10.3390\/ijms231911516","volume":"23","author":"L Allegri","year":"2022","unstructured":"Allegri, L., Baldan, F., Molteni, E., Mio, C. & Damante, G. Role of m6A RNA methylation in thyroid cancer cell lines. Int. J. Mol. Sci. 23, 11516. https:\/\/doi.org\/10.3390\/ijms231911516 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"35712_CR20","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/j.ymthe.2021.01.019","volume":"29","author":"J He","year":"2021","unstructured":"He, J. et al. METTL3 restrains papillary thyroid cancer progression via m6A\/c-Rel\/IL-8-mediated neutrophil infiltration. Mol. Ther. 29, 1821\u20131837. https:\/\/doi.org\/10.1016\/j.ymthe.2021.01.019 (2021).","journal-title":"Mol. Ther."},{"key":"35712_CR21","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41419-022-04817-6","volume":"13","author":"Y Zhu","year":"2022","unstructured":"Zhu, Y. et al. METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition. Cell Death Dis. 13, 358. https:\/\/doi.org\/10.1038\/s41419-022-04817-6 (2022).","journal-title":"Cell Death Dis."},{"key":"35712_CR22","doi-asserted-by":"publisher","unstructured":"Huang, C., Duan, Z., Chen, B., Xia, H. & Wang, G. LncRNA LINC00969 modified by METTL3 attenuates papillary thyroid cancer progression in an m6A-dependent manner. Adv. Clin. Exp. Med. 34, 0\u20130. https:\/\/doi.org\/10.17219\/acem\/188367 (2024).","DOI":"10.17219\/acem\/188367"},{"key":"35712_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.semcancer.2019.05.019","volume":"64","author":"SM Ferrari","year":"2020","unstructured":"Ferrari, S. M. et al. Thyroid autoimmune disorders and cancer. Semin. Cancer Biol. 64, 135\u2013146. https:\/\/doi.org\/10.1016\/j.semcancer.2019.05.019 (2020).","journal-title":"Semin. Cancer Biol."},{"key":"35712_CR24","doi-asserted-by":"publisher","unstructured":"Wu, S. et al. N6-Methyladenosine and rheumatoid arthritis: A comprehensive review. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.731842 (2021).","DOI":"10.3389\/fimmu.2021.731842"},{"key":"35712_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116066","volume":"170","author":"Y Xu","year":"2024","unstructured":"Xu, Y., Liu, W. & Ren, L. Emerging roles and mechanism of m6A methylation in rheumatoid arthritis. Biomed. Pharmacother. 170, 116066. https:\/\/doi.org\/10.1016\/j.biopha.2023.116066 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"35712_CR26","doi-asserted-by":"publisher","unstructured":"Lv, X. et al. RNA methylation in systemic lupus erythematosus. Front. Cell Dev. Biol. https:\/\/doi.org\/10.3389\/fcell.2021.696559 (2021).","DOI":"10.3389\/fcell.2021.696559"},{"key":"35712_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.149125","volume":"936","author":"Z Li","year":"2025","unstructured":"Li, Z. et al. N6-methyladenosine in inflammatory diseases: Important actors and regulatory targets. Gene 936, 149125. https:\/\/doi.org\/10.1016\/j.gene.2024.149125 (2025).","journal-title":"Gene"},{"key":"35712_CR28","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1080\/08830185.2023.2280544","volume":"43","author":"L Li","year":"2024","unstructured":"Li, L. et al. RNA methylation: A potential therapeutic target in autoimmune disease. Int. Rev. Immunol. 43, 160\u2013177. https:\/\/doi.org\/10.1080\/08830185.2023.2280544 (2024).","journal-title":"Int. Rev. Immunol."},{"key":"35712_CR29","doi-asserted-by":"publisher","unstructured":"Tang, L. et al. Emerging perspectives of RNA N6-methyladenosine (m6A) modification on immunity and autoimmune diseases. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.630358 (2021).","DOI":"10.3389\/fimmu.2021.630358"},{"key":"35712_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106933","volume":"196","author":"K Mo","year":"2023","unstructured":"Mo, K. et al. Targeting hnRNPC suppresses thyroid follicular epithelial cell apoptosis and necroptosis through m6A-modified ATF4 in autoimmune thyroid disease. Pharmacol. Res. 196, 106933. https:\/\/doi.org\/10.1016\/j.phrs.2023.106933 (2023).","journal-title":"Pharmacol. Res."},{"key":"35712_CR31","doi-asserted-by":"publisher","unstructured":"Song, R.-h., Du, P., Gao, C.-q., Liu, X.-r. & Zhang, J.-a. METTL3 Is involved in the development of Graves\u2019 disease by inducing SOCS mRNA m6A modification. Front. Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2021.666393 (2021).","DOI":"10.3389\/fendo.2021.666393"},{"key":"35712_CR32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.gendis.2022.05.008","volume":"10","author":"X Li","year":"2023","unstructured":"Li, X. et al. The essential role of N6-methyladenosine RNA methylation in complex eye diseases. Genes Diseases 10, 505\u2013520. https:\/\/doi.org\/10.1016\/j.gendis.2022.05.008 (2023).","journal-title":"Genes Diseases"},{"key":"35712_CR33","doi-asserted-by":"publisher","unstructured":"Kanehisa, M., Sato, Y, Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457\u2013D462, https:\/\/doi.org\/10.1093\/nar\/gkv1070 (2016).","DOI":"10.1093\/nar\/gkv1070"},{"key":"35712_CR34","doi-asserted-by":"crossref","unstructured":"Kanehisa M & S, G. KEGG kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","DOI":"10.1093\/nar\/28.1.27"},{"key":"35712_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-72020-y","author":"J Xia","year":"2024","unstructured":"Xia, J., Shi, Y. & Chen, X. New insights into the mechanisms of the extracellular matrix and its therapeutic potential in anaplastic thyroid carcinoma. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-024-72020-y (2024).","journal-title":"Sci. Rep."},{"key":"35712_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70060","author":"Y Qin","year":"2024","unstructured":"Qin, Y., Ding, W., Wu, X. & Qin, D. Dabrafenib inhibits Egr-1-mediated adhesion of thyroid cancer cells to pulmonary microvascular endothelium. J. Biochem. Mol. Toxicol. https:\/\/doi.org\/10.1002\/jbt.70060 (2024).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"35712_CR37","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1007\/s12035-022-02739-0","volume":"59","author":"N Zhang","year":"2022","unstructured":"Zhang, N., Ding, C., Zuo, Y., Peng, Y. & Zuo, L. N6-methyladenosine and neurological diseases. Mol. Neurobiol. 59, 1925\u20131937. https:\/\/doi.org\/10.1007\/s12035-022-02739-0 (2022).","journal-title":"Mol. Neurobiol."},{"key":"35712_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101764","volume":"37","author":"J Qin","year":"2023","unstructured":"Qin, J. et al. IGF2BP3 drives gallbladder cancer progression by m6A-modified CLDN4 and inducing macrophage immunosuppressive polarization. Transl. Oncol. 37, 101764. https:\/\/doi.org\/10.1016\/j.tranon.2023.101764 (2023).","journal-title":"Transl. Oncol."},{"key":"35712_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2023.131370","volume":"453","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. An analysis of differentially expressed and differentially m6A-modified transcripts in soybean roots treated with lead. J. Hazard. Mater. 453, 131370. https:\/\/doi.org\/10.1016\/j.jhazmat.2023.131370 (2023).","journal-title":"J. Hazard. Mater."},{"key":"35712_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.dci.2022.104434","volume":"133","author":"Y Shao","year":"2022","unstructured":"Shao, Y., Duan, X., Zhao, X., Lv, Z. & Li, C. Global N6-methyladenosine methylation analysis reveals the positive correlation between m6A modification and mRNA abundance during Apostichopus japonicus disease development. Dev. Comp. Immunol. 133, 104434. https:\/\/doi.org\/10.1016\/j.dci.2022.104434 (2022).","journal-title":"Dev. Comp. Immunol."},{"key":"35712_CR41","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang, H. et al. Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat. Cell Biol. 20, 285\u2013295. https:\/\/doi.org\/10.1038\/s41556-018-0045-z (2018).","journal-title":"Nat. Cell Biol."},{"key":"35712_CR42","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1186\/s12885-023-11361-9","volume":"23","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. YTHDF3as a prognostic predictive biomarker of thyroid cancer and its correlation with immune infiltration. BMC Cancer 23, 882. https:\/\/doi.org\/10.1186\/s12885-023-11361-9 (2023).","journal-title":"BMC Cancer"},{"key":"35712_CR43","first-page":"1902","volume":"52","author":"H Han","year":"2023","unstructured":"Han, H. et al. Expression and prognostic value of m6A RNA methylation-related genes in thyroid cancer. Iran J. Public Health. 52, 1902\u20131916 (2023).","journal-title":"Iran J. Public Health."},{"key":"35712_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.795386","volume":"12","author":"R Sa","year":"2021","unstructured":"Sa, R., Guo, M., Liu, D. & Guan, F. AhR antagonist promotes differentiation of papillary thyroid cancer via regulating circSH2B3\/miR-4640-5P\/IGF2BP2 axis. Front. Pharmacol. 12, 795386. https:\/\/doi.org\/10.3389\/fphar.2021.795386 (2021).","journal-title":"Front. Pharmacol."},{"key":"35712_CR45","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.3390\/cancers14051268","volume":"14","author":"R Sa","year":"2022","unstructured":"Sa, R. et al. Targeting IGF2BP2 promotes differentiation of radioiodine refractory papillary thyroid cancer via destabilizing RUNX2 mRNA. Cancers 14, 1268. https:\/\/doi.org\/10.3390\/cancers14051268 (2022).","journal-title":"Cancers"},{"key":"35712_CR46","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41417-023-00702-2","volume":"31","author":"W Wang","year":"2023","unstructured":"Wang, W., Ding, Y., Zhao, Y. & Li, X. m6A reader IGF2BP2 promotes lymphatic metastasis by stabilizing DPP4 in papillary thyroid carcinoma. Cancer Gene Ther. 31, 285\u2013299. https:\/\/doi.org\/10.1038\/s41417-023-00702-2 (2023).","journal-title":"Cancer Gene Ther."},{"key":"35712_CR47","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12935-020-01283-y","volume":"20","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Identification and validation of m6A RNA methylation regulators with clinical prognostic value in Papillary thyroid cancer. Cancer Cell Int. 20, 203. https:\/\/doi.org\/10.1186\/s12935-020-01283-y (2020).","journal-title":"Cancer Cell Int."},{"key":"35712_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1594","volume":"14","author":"K Yan","year":"2024","unstructured":"Yan, K. et al. Spatial transcriptomics reveals prognosis-associated cellular heterogeneity in the papillary thyroid carcinoma microenvironment. Clin. Transl. Med. 14, e1594. https:\/\/doi.org\/10.1002\/ctm2.1594 (2024).","journal-title":"Clin. Transl. Med."},{"key":"35712_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.862313","volume":"12","author":"Z Chen","year":"2022","unstructured":"Chen, Z. et al. Single-cell RNA sequencing revealed a 3-gene panel predicted the diagnosis and prognosis of thyroid papillary carcinoma and associated with tumor immune microenvironment. Front. Oncol. 12, 862313. https:\/\/doi.org\/10.3389\/fonc.2022.862313 (2022).","journal-title":"Front. Oncol."},{"key":"35712_CR50","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/ott.s149613","volume":"11","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Upregulated LAMB3 increases proliferation and metastasis in thyroid cancer. Onco. Targets. Ther. 11, 37\u201346. https:\/\/doi.org\/10.2147\/ott.s149613 (2017).","journal-title":"Onco. Targets. Ther."},{"key":"35712_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e27928","volume":"10","author":"L Pan","year":"2024","unstructured":"Pan, L., Zhang, L., Fu, J., Shen, K. & Zhang, G. Integrated transcriptome sequencing and weighted gene co-expression network analysis reveals key genes of papillary thyroid carcinomas. Heliyon 10, e27928. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27928 (2024).","journal-title":"Heliyon"},{"key":"35712_CR52","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000513338","volume":"88","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Long noncoding RNA GAS5 targeting miR-221-3p\/cyclin-dependent kinase inhibitor 2B axis regulates follicular thyroid carcinoma cell cycle and proliferation. Pathobiology 88, 289\u2013300. https:\/\/doi.org\/10.1159\/000513338 (2021).","journal-title":"Pathobiology"},{"key":"35712_CR53","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/s41388-024-02956-y","volume":"43","author":"Z Chen","year":"2024","unstructured":"Chen, Z. et al. METTL3 promotes cellular senescence of colorectal cancer via modulation of CDKN2B transcription and mRNA stability. Oncogene 43, 976\u2013991. https:\/\/doi.org\/10.1038\/s41388-024-02956-y (2024).","journal-title":"Oncogene"},{"key":"35712_CR54","doi-asserted-by":"publisher","first-page":"23647","DOI":"10.1002\/jcp.28932","volume":"234","author":"L Liu","year":"2019","unstructured":"Liu, L. et al. Identification of key genes and pathways of thyroid cancer by integrated bioinformatics analysis. J. Cell. Physiol. 234, 23647\u201323657. https:\/\/doi.org\/10.1002\/jcp.28932 (2019).","journal-title":"J. Cell. Physiol."},{"key":"35712_CR55","first-page":"1668","volume":"15","author":"YMW Zeng","year":"2023","unstructured":"Zeng, Y. M. W. et al. Identification and validation of eight estrogen-related genes for predicting prognosis of papillary thyroid cancer. Aging 15, 1668\u20131684 (2023).","journal-title":"Aging"},{"key":"35712_CR56","doi-asserted-by":"publisher","unstructured":"S., K. TMPRSS4, a type II transmembrane serine protease, as a potential therapeutic target in cancer. Exp. Mol. Med. 55, 716\u2013724. https:\/\/doi.org\/10.1038\/s12276-023-00975-5 (2023).","DOI":"10.1038\/s12276-023-00975-5"},{"key":"35712_CR57","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12902-022-01203-3","volume":"22","author":"X Xu","year":"2022","unstructured":"Xu, X., Sun, T. & Jing, J. TMPRSS4 is a novel biomarker and correlated with immune infiltration in thyroid carcinoma. BMC Endocr. Disord. 22, 280. https:\/\/doi.org\/10.1186\/s12902-022-01203-3 (2022).","journal-title":"BMC Endocr. Disord."},{"key":"35712_CR58","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1177\/17246008211046368","volume":"36","author":"X-F Zhao","year":"2021","unstructured":"Zhao, X.-F., Yang, Y.-S., Gao, D.-Z. & Park, Y. K. TMPRSS4 overexpression promotes the metastasis of colorectal cancer and predicts poor prognosis of stage III\u2013IV colorectal cancer. Int. J. Biol. Mark. 36, 23\u201332. https:\/\/doi.org\/10.1177\/17246008211046368 (2021).","journal-title":"Int. J. Biol. Mark."},{"key":"35712_CR59","doi-asserted-by":"publisher","first-page":"4538","DOI":"10.1002\/ptr.7156","volume":"35","author":"BS Oh","year":"2021","unstructured":"Oh, B. S. et al. Inhibition of TMPRSS4 mediated epithelial-mesenchymal transition is critically involved in antimetastatic effect of melatonin in colorectal cancers. Phytother. Res. 35, 4538\u20134546. https:\/\/doi.org\/10.1002\/ptr.7156 (2021).","journal-title":"Phytother. Res."},{"key":"35712_CR60","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2147\/jhc.s404008","volume":"10","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. LncRNA TGFB2-OT1 promotes progression and angiogenesis in hepatocellular carcinoma by dephosphorylating \u03b2-catenin. J. Hepatocell. Carcinoma 10, 429\u2013446. https:\/\/doi.org\/10.2147\/jhc.s404008 (2023).","journal-title":"J. Hepatocell. Carcinoma"},{"key":"35712_CR61","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/cam4.1047","volume":"6","author":"P Song","year":"2017","unstructured":"Song, P. et al. A three-lncRNA expression signature associated with the prognosis of gastric cancer patients. Cancer Med. 6, 1154\u20131164. https:\/\/doi.org\/10.1002\/cam4.1047 (2017).","journal-title":"Cancer Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35712-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35712-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35712-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T23:02:49Z","timestamp":1770764569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35712-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["35712"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-35712-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"7 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5688"}}